Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells.
Jacobsen, Jeffery R
Crooks, Gay M
AffiliationUniv Arizona, Coll Med Phoenix, Dept Basic Med Sci
Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth Phoenix, Dept Epidemiol & Biostat
KeywordsAcute myelogenous leukemia
Hematopoietic stem cells
Umbilical cord blood
MetadataShow full item record
CitationBapat, A. , Keita, N. , Martelly, W. , Kang, P. , Seet, C. , Jacobsen, J. R., Stoilov, P. , Hu, C. , Crooks, G. M. and Sharma, S. (2018), Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2‐M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells. Stem Cells, 36: 1663-1675. doi:10.1002/stem.2885
Rights© 2018 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractMyeloid malignancies, including myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia, are characterized by abnormal proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs). Reports on analysis of bone marrow samples from patients have revealed a high incidence of mutations in splicing factors in early stem and progenitor cell clones, but the mechanisms underlying transformation of HSPCs harboring these mutations remain unknown. Using ex vivo cultures of primary human CD34(+) cells as a model, we find that mutations in splicing factors SRSF2 and U2AF1 exert distinct effects on proliferation and differentiation of HSPCs. SRSF2 mutations cause a dramatic inhibition of proliferation via a G2-M phase arrest and induction of apoptosis. U2AF1 mutations, conversely, do not significantly affect proliferation. Mutations in both SRSF2 and U2AF1 cause abnormal differentiation by skewing granulo-monocytic differentiation toward monocytes but elicit diverse effects on megakaryo-erythroid differentiation. The SRSF2 mutations skew differentiation toward megakaryocytes whereas U2AF1 mutations cause an increase in the erythroid cell populations. These distinct functional consequences indicate that SRSF2 and U2AF1 mutations have cell context-specific effects and that the generation of myeloid disease phenotype by mutations in the genes coding these two proteins likely involves different intracellular mechanisms. Stem Cells 2018;36:1663-1675
Note6 month embargo; first published: 13 July 2018
VersionFinal accepted manuscript
SponsorsBroad Stem Cell Research Center at University of California, Los Angeles (UCLA); Arizona Cord Blood Program; UCLA Center for AIDS Research Virology Core Lab [5P30 AI028697]; National Institutes of Health/National Cancer Institute [R21CA170786]; American Cancer Society [74-001-34-IRG]; Arizona Area Health Education Centers (AzAHEC) program; Department of Defense Breast Cancer Research program [BC142286]; National Institutes of Health/National Center for Advancing Translational Science [KL2TR001882]; UCLA Broad Stem Cell Research Center clinical fellowship; Flow Cytometry Core Facilities at the University of Arizona College of MedicinePhoenix
- Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
- Authors: Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH
- Issue date: 2013 Jul
- Physiological <i>Srsf2</i> P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice.
- Authors: Kon A, Yamazaki S, Nannya Y, Kataoka K, Ota Y, Nakagawa MM, Yoshida K, Shiozawa Y, Morita M, Yoshizato T, Sanada M, Nakayama M, Koseki H, Nakauchi H, Ogawa S
- Issue date: 2018 Feb 8
- Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
- Authors: Choi HW, Kim HR, Baek HJ, Kook H, Cho D, Shin JH, Suh SP, Ryang DW, Shin MG
- Issue date: 2015 Jan
- Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes.
- Authors: Wu L, Song L, Xu L, Chang C, Xu F, Wu D, He Q, Su J, Zhou L, Xiao C, Zhang Z, Zhao Y, Chen S, Li X
- Issue date: 2016 Apr
- Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
- Authors: Hamilton BK, Visconte V, Jia X, Tabarroki A, Makishima H, Hasrouni E, Abounader D, Kalaycio M, Sekeres MA, Sobecks R, Duong Liu H, Bolwell B, Maciejewski JP, Copelan E, Tiu RV
- Issue date: 2016 Jun